Empyrean Cashews IPO vs Global Longlife Hospital IPO

Comparison between Empyrean Cashews IPO and Global Longlife Hospital IPO.

IPO Details

Empyrean Cashews IPO is a SME Fixed Price IPO proposed to list at NSE SME while Global Longlife Hospital IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Empyrean Cashews IPO is up to ₹18.44 Cr whereas the issue size of the Global Longlife Hospital IPO is up to ₹46.54 Cr. The final issue price of Empyrean Cashews IPO is ₹37.00 per share and of Global Longlife Hospital IPO is ₹140.00 per share.

 Empyrean Cashews IPOGlobal Longlife Hospital IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)₹37.00 per share₹140.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)
Market Lot Size3000 shares1000 shares
Fresh Issue Size49,83,000 shares33,24,000 shares
Fresh Issue Size (Amount)up to ₹18.44 Crup to ₹46.54 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total49,83,000 shares33,24,000 shares
Issue Size Total (Amount)up to ₹18.44 Crup to ₹46.54 Cr

IPO Timetable

Empyrean Cashews IPO opens on Mar 21, 2022, while Global Longlife Hospital IPO opens on Apr 21, 2022. The closing date of Empyrean Cashews IPO and Global Longlife Hospital IPO is Mar 23, 2022, and Apr 25, 2022, respectively.

Financials & KPIs

Empyrean Cashews IPO P/E ratio is 25.69, as compared to Global Longlife Hospital IPO P/E ratio of 38.04.

 Empyrean Cashews IPOGlobal Longlife Hospital IPO
Financials

Company Financials ()

Period Ended
Amount in ₹ Crore

Company Financials ()

Period Ended
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)56.9981.43
Promoter Shareholding (Post-Issue)41.8854.29
P/E Ratio25.6938.04
Market Cap₹73.24 Cr.₹147.00 Cr.
ROE
ROCE
Debt/Equity1.36
EPS₹0.46₹1.48
RoNW3.4411.54

Shares Offered

In the Empyrean Cashews IPO Retail Individual Investors (RII) are offered 24,91,500 shares while in Global Longlife Hospital IPO retail investors are offered 24,91,500 shares. Qualified Institutional Buyers (QIB) are offered in Empyrean Cashews IPO and in Global Longlife Hospital IPO.

 Empyrean Cashews IPOGlobal Longlife Hospital IPO
Anchor Investor Reservation
Market Maker Reservation2,64,000 shares1,76,000 shares
QIB
NII24,91,500 shares16,62,000 shares
RII24,91,500 shares16,62,000 shares
Employee
Others
Total49,83,000 shares33,24,000 shares

Bids Received (Subscription)

Empyrean Cashews IPO subscribed 2.28x in total, whereas Global Longlife Hospital IPO subscribed 1.50x.

Compare with others

Compare: